All Comments by Elliott Mufson
- Can a Sex Hormone Boost Cognition in Down’s Syndrome?
- John Trojanowski, 75, a Giant in the Field of Neuropathology
- New PET Tracer Binds Muscarinic Acetylcholine Receptors
- Peter Davies, Beloved Giant of Alzheimer’s Disease Research, Dies at 72
- Are Cholinergic Neurons “Patient Zero” of Alzheimer’s Disease?
- Axonally synthesized ATF4 transmits a neurodegenerative signal across brain regions.
- A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
- Testing the right target and right drug at the right stage.
- Anti-Aβ Oligomer Headed for Phase 3 Clinical Trial
- Amyloid-beta peptide oligomers disrupt axonal transport through an NMDA receptor-dependent mechanism that is mediated by glycogen synthase kinase 3beta in primary cultured hippocampal neurons.
- Caspase activation precedes and leads to tangles.
- Paper Alert-cum-SfN: Bapineuzumab Published, More AN1792 Presented
- The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
- Gambogic amide, a selective agonist for TrkA receptor that possesses robust neurotrophic activity, prevents neuronal cell death.
- eFAD Research Surprise: In Mutation Carriers, Amyloid Starts in Striatum